Are you a DTx or Pharma company seeking to successfully navigate both fully-insured and self-insured health plan segments to get your DTx products reimbursed in the US? Join this US-focused interactive masterclass led by biopharma and DTx reimbursement expert Mike Pace to learn more about it and share your experience with the group.
We have seen a significant number of DTx companies approaching employers (both fully-insured and self-insured) to get their products paid for as a covered employee benefit. While some have secured good deals and continue to make good adoption progress, there are many challenges to make it work; especially given the crowded and competitive nature of DTx offerings to employers. In this masterclass, Mike Pace will walk us through:
What are the drivers for employer funding of DTx? How different are they between fully-insured vs. self-insured plans and how are they changing?
What differentiated value propositions are best suited for fully-insured vs self-insured health plan DTx buyers?
The role of brokers, benefit consultants, consortiums and navigator platforms in the employer reimbursement and US DTx go-to-market path
Types of contracts & pricing through direct and reseller channels